Direct-acting antivirals for chronic hepatitis C: risk of hypoglycaemia in patients with diabetes
Medicines and Healthcare products Regulatory Agency(MHRA) has issued a safety alert advising to monitor glucose levels closely in patients with diabetes during direct-acting antiviral therapy for hepa
Source: Royal Pharmaceutical Society News - Category: Drugs & Pharmacology Source Type: news
More News: Antiviral Therapy | Diabetes | Drugs & Pharmacology | Endocrinology | Hepatitis | Hepatitis C